Concepedia

K. Coote

KC

9

Publications

418

Citations

9

H-Index

2004

Active since

Affiliations

Novartis (United Kingdom)(Current)

Novartis (Switzerland)

Cystic Fibrosis Foundation

Novartis Foundation

Mount Sinai Medical Center

K. Coote is an author at Novartis (United Kingdom) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2004–2022

9

Publications

9

Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope

Tingting Jiang, Jordana M. Henderson, K. Coote et al. · Nature Communications · 2020 · 102 citations · Full text

Camostat Attenuates Airway Epithelial Sodium Channel Function in Vivo through the Inhibition of a Channel-Activating Protease

K. Coote, Hazel C. Atherton-Watson, Rosemary Sugar et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 93 citations

Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect

Christopher S. Stevenson, K. Coote, Ruth Webster et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2004 · 91 citations

A multimodal iPSC platform for cystic fibrosis drug testing

Andrew Berical, Rhianna E. Lee, Junjie Lu et al. · Nature Communications · 2022 · 38 citations · Full text

Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: Quaternary amines

Thomas A. Hunt, Hazel C. Atherton-Watson, Jake Axford et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 28 citations · Full text

, , +12

Rows per page

1–5 of 9